Literature DB >> 10968891

Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources.

S W Reddel1, Y X Wang, Y H Sheng, S A Krilis.   

Abstract

This paper examines the methodology of anti-beta(2)-glycoprotein I (beta(2)-GPI) epitope determination and provides further epitope studies using human sera containing anti-beta(2)-GPI autoantibodies. Studies in this field may be misleading as the antigen coating density using mutant forms of beta(2)-GPI may be below the threshold required for monogamous divalent binding by low affinity anti-beta(2)-GPI autoantibodies, while being easily detected by high affinity anti-beta(2)-GPI from immunized animals. The antigen density threshold effect is found in anti-beta(2)-GPI autoantibodies from humans and from monoclonal anti-beta(2)-GPI derived from mice with models of autoimmune disease. Anti-beta(2)-GPI from an autoimmune mouse and from 18/21 human sera did not bind above background levels to a domain-I-deleted mutant. In addition, single point mutations in domain I result in dramatic changes in the binding of many human sera containing anti-beta(2)-GPI. These findings support a conclusion that domain I of beta(2)-GPI contains significant epitopes for the anti-beta(2)-GPI antibodies found in the antiphospholipid syndrome. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968891     DOI: 10.1006/jaut.2000.0427

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  19 in total

Review 1.  Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?

Authors:  Pier Luigi Meroni; Cristina Luzzana; Donatella Ventura
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

Review 2.  New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.

Authors:  Cecilia Beatrice Chighizola; Maria Gerosa; Pier Luigi Meroni
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 3.  New insights into the biology and pathobiology of beta2-glycoprotein I.

Authors:  Bill Giannakopoulos; Peyman Mirarabshahi; Steven A Krilis
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 4.  Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Authors:  Douglas B Cines; Keith R McCrae; X Long Zheng; Bruce S Sachais; Eline T Luning Prak; Don L Siegel
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

5.  Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.

Authors:  Yiannis Ioannou; Charis Pericleous; Ian Giles; David S Latchman; David A Isenberg; Anisur Rahman
Journal:  Arthritis Rheum       Date:  2007-01

6.  Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1.

Authors:  F H Passam; S Rahgozar; M Qi; M J Raftery; J W H Wong; K Tanaka; Y Ioannou; J Y Zhang; R Gemmell; J C Qi; B Giannakopoulos; W E Hughes; P J Hogg; S A Krilis
Journal:  J Thromb Haemost       Date:  2010-08       Impact factor: 5.824

7.  Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.

Authors:  Charis Pericleous; Jennifer Miles; Diego Esposito; Acely Garza-Garcia; Paul C Driscoll; Anastasia Lambrianides; David Latchman; David Isenberg; Anisur Rahman; Yiannis Ioannou; Ian Giles
Journal:  Mol Immunol       Date:  2011-09-06       Impact factor: 4.407

8.  Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis.

Authors:  Charis Pericleous; Patricia Ruiz-Limón; Zurina Romay-Penabad; Ana Carrera Marín; Acely Garza-Garcia; Lucy Murfitt; Paul C Driscoll; David S Latchman; David A Isenberg; Ian Giles; Yiannis Ioannou; Anisur Rahman; Silvia S Pierangeli
Journal:  Rheumatology (Oxford)       Date:  2014-09-30       Impact factor: 7.580

9.  Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.

Authors:  Katie Poulton; Vera M Ripoll; Charis Pericleous; Pier Luigi Meroni; Maria Gerosa; Yiannis Ioannou; Anisur Rahman; Ian P Giles
Journal:  Am J Reprod Immunol       Date:  2014-12-02       Impact factor: 3.886

10.  A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli.

Authors:  Yiannis Ioannou; Ian Giles; Anastasia Lambrianides; Chris Richardson; Laurence H Pearl; David S Latchman; David A Isenberg; Anisur Rahman
Journal:  BMC Biotechnol       Date:  2006-02-10       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.